Management of bleeding GI tumors.

摘要

GI bleeding (GIB) in the cancer patient is a common and challenging clinical problem. Although the majority of bleeding episodes stem from traditional, noncancer causes of GIB, the source of hemorrhage may also be the cancer itself (primary or metastatic) or a consequence of its treatment. Tumors primary and metastatic to the GI tract are at risk of bleeding.1 The neutropenia and thrombocytopenia often present in cancer patients complicate the approach to diagnosis and therapy. Treatment options involve the interventional radiologist, radiation oncologist, or surgeon, as well as the gastroenterologist. Clinical care is optimized by access to a multidisciplinary team.